Real-world experience with riociguat as potential bridging therapy in patients with chronic thromboembolic pulmonary hypertension: a case series

Vijay P Balasubramanian; Matthew Beutner; Kirat Gill; Monika Kakol; Lana Melendres-Groves

doi:10.1177/2045894019898377

Real-world experience with riociguat as potential bridging therapy in patients with chronic thromboembolic pulmonary hypertension: a case series

Pulm Circ. 2020 Apr 16;10(2):2045894019898377. doi: 10.1177/2045894019898377. eCollection 2020 Apr-Jun.

Authors

Vijay P Balasubramanian¹, Matthew Beutner¹, Kirat Gill¹, Monika Kakol^{1

2}, Lana Melendres-Groves^{1

2}

Affiliations

¹ Division of Pulmonary Disease and Critical Care Medicine, University of California, Fresno, CA, USA.
² University of New Mexico medical center at Albuquerque, NM, USA.

No abstract available

Keywords: chronic thromboembolic pulmonary hypertension; pulmonary embolism; pulmonary endarterectomy; pulmonary hypertension; pulmonary thromboendarterectomy.

Publication types

Case Reports